Quieter Food Thoughts Are Not the Same as Treating Binge-Eating Disorder

Name the problem without judging it

If I felt out of control around food, I would want support without having to prove I deserve it. I would also want the prescriber to distinguish appetite, persistent food thoughts and binge-eating disorder. Those terms can overlap in everyday conversation, but they do not mean the same thing in a treatment plan.

I would describe the loss of control and distress, not just the quantity eaten or my weight. My food-tolerance guide addresses difficulty eating on treatment; it does not diagnose an eating disorder. I would not assume a smaller appetite automatically means the underlying concern is resolved.

A promising idea needs the right outcome

A 17-week randomized pilot trial tested liraglutide 3 mg in 27 adults with binge-eating disorder. Binge episodes decreased in both the medicine and placebo groups, but the difference was not statistically significant. Remission rates also did not differ, although weight loss was greater with liraglutide¹.

I would be careful with the headline “GLP-1s treat binge eating.” This small study tested liraglutide, not every drug in the class. A dispensing error was a major limitation. The results leave room for further research; they do not establish that semaglutide or tirzepatide can replace established disorder-focused treatment.

Weight loss is not the same as recovery

I would ask the team to measure the outcome that matters: loss-of-control episodes, distress, eating patterns and daily functioning. A changing scale cannot answer all of those questions. I would also ask whether my treatment is making it harder to eat enough during the day, even if other appetite-related symptoms feel quieter.

If I were skipping meals because I felt nauseated, I would tell both the prescriber and the person helping with eating concerns. My side-effect guide can help organize that conversation. I would not frame an inability to eat as success simply because a weight-loss program rewards smaller numbers.

Established care deserves a place in the plan

NIDDK describes treatment approaches that include psychotherapy, behavioral strategies and medicines. It identifies cognitive behavioral, interpersonal and dialectical behavior therapies among approaches that can help². I would ask for someone experienced with eating disorders rather than assume a general weight-loss intake covers this need.

A later randomized trial examined cognitive behavioral therapy, lisdexamfetamine and their combination for binge-eating disorder with obesity³. I would not choose a treatment by comparing headlines across unrelated trials. The reason to mention that study is that disorder-specific treatment has its own evidence and deserves an individualized discussion.

Tell the clinician what is happening between appointments

I would bring a brief description of episodes: how often they happen, whether I feel unable to stop, what distress follows and whether I am compensating afterward. I would include a past eating-disorder diagnosis and previous treatment. I would want a private conversation without a child listening to details that are difficult to discuss.

I would also mention mood changes. My mood guide covers another reason to contact the team. If shame makes me minimize the problem, I would consider writing it down first. A message that says “I need help with loss-of-control eating” can be enough to start.

Avoid building treatment around restriction alone

I would ask how the plan supports regular, adequate nourishment and what to do when the appetite effect is strong. I would not invent a calorie target from the trial or assume that a stricter diet is the missing ingredient. I would want advice that considers both obesity treatment and the eating concern.

My protein guide is general nutrition reading, not an eating-disorder treatment prescription. If food tracking becomes distressing, I would say so and ask for a different approach. A plan that looks orderly on paper may still need changes to be workable for me.

Ask who is responsible for follow-up

Before starting or continuing a GLP-1, I would ask who assesses symptoms, how progress is reviewed and when additional support is needed. If separate clinicians are involved, I would ask them to coordinate rather than leave me to carry contradictory advice between services.

I would not demand that a medicine solve every difficult thought about food, or dismiss relief when it occurs. My goal would be honest monitoring of both benefits and problems, with care directed at the actual condition. Improvement can matter without being proof that the evidence is settled.